ArticleJournal for immunotherapy of cancer2025

Engineering TME-activated CD47-specific CAR macrophage via Arg1 promoter for safe and effective solid tumor immunotherapy.

Fuyu Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.